Highlights and Quick Summary
- Beginning Cash for the quarter ending September 30, 2023 was $0 (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly Beginning Cash decreased by NaN%
- Annual Beginning Cash for 2022 was $199 Million (a 436.97% increase from previous year)
- Annual Beginning Cash for 2021 was $37 Million (a 327.6% increase from previous year)
- Twelve month Beginning Cash ending September 30, 2023 was $201 Million (a 0.0% decrease compared to previous quarter)
- Twelve month trailing Beginning Cash increased by 1.29% year-over-year
Trailing Beginning Cash for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| $201 Million | $201 Million | $201 Million | $199 Million |
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Beginning Cash of Prime Medicine, Inc.
Most recent Beginning Cashof PRME including historical data for past 10 years.Interactive Chart of Beginning Cash of Prime Medicine, Inc.
Prime Medicine, Inc. Beginning Cash for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $0.0 | $0.0 | $201.12 | – | – |
| 2022 | $0.0 | $0.0 | $0.0 | $198.55 | $198.55 |
| 2021 | – | – | $0.0 | $36.98 | $36.98 |
| 2020 | $8.65 | – | – | – | $8.65 |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology